How to Get Ozempic Without Insurance in 2026
Ozempic's list price is $998 per month, and unlike its sister drug Wegovy, there is no NovoCare self-pay program for Ozempic. The realistic cash-pay paths bring it down to roughly $199–$399/month in May 2026. For most non-diabetic cash-pay patients, switching to Wegovy is the better move on both cost and weight-loss outcomes.
The honest answer first: most cash-pay patients should switch to Wegovy
Ozempic and Wegovy are the exact same molecule (semaglutide). Ozempic is the type 2 diabetes brand; Wegovy is the weight-loss brand. Novo Nordisk only offers a NovoCare self-pay program for Wegovy — starting around $499/month. Wegovy also has a higher max dose (2.4 mg vs Ozempic's 2.0 mg), which translates to 14.9% peak weight loss vs Ozempic's 11.6% in trial data. If you do not have a type 2 diabetes diagnosis, almost no insurer will cover Ozempic, and your cheapest path is Wegovy NovoCare.
Read on if you specifically need Ozempic (e.g. you have diabetes coverage), or skip ahead to How to Get Wegovy Without Insurance.
Cash-pay Ozempic paths at a glance
| Path | Monthly | Annual |
|---|---|---|
| Ozempic Savings Card (commercial insurance + diabetes Dx) | ~$25 | ~$300 |
| Switch to Wegovy NovoCare (same molecule) | $499 | $5,988 |
| Compounded semaglutide via telehealth | $199 | $2,388 |
| Branded Ozempic via telehealth | $399 | $4,788 |
| Cash retail (full WAC) | $998 | $11,976 |
1. Ozempic Savings Card (if you have commercial insurance + a T2D diagnosis)
If your commercial insurance covers Ozempic for type 2 diabetes but the copay is high, the Novo Nordisk Ozempic Savings Card typically drops the copay to around $25/month. Apply at ozempic.com.
Government insurance — Medicare, Medicaid, Tricare, VA — is excluded by federal anti-kickback rules. If you have one of those plans, the savings card will not work regardless of your diagnosis.
See our full GLP-1 Savings Cards guide for the program details and eligibility.
2. Switch to Wegovy NovoCare ($499/mo)
Wegovy is the exact same molecule as Ozempic — semaglutide— just the weight-loss-indicated brand instead of the diabetes-indicated brand. Novo Nordisk's NovoCare self-pay reference price for Wegovy is approximately $499/month, versus an Ozempic WAC of $998with no manufacturer self-pay alternative.
This is the cheapest legitimate cash-pay path to semaglutide in 2026 if you can use the Wegovy brand. Apply at novocare.com. Wegovy also has a higher max dose (2.4 mg vs 2.0 mg), which shows up as 14.9% peak weight loss in STEP-1 versus 11.6% for Ozempic — so for weight-loss outcomes you also do better.
Visit NovoCare →3. Compounded semaglutide (~$199/mo, where available)
Compounded semaglutide is a personalized formulation made by a US-licensed 503A compounding pharmacy. The FDA officially ended the semaglutide shortage in 2024–2025, narrowing the regulatory shield, but some 503A pharmacies continue to produce case-by-case formulations through licensed telehealth.
As of May 2026, expect availability and pricing to vary by state and platform. Pricing typically lands in the $199/month range. Avoid any "research-grade" or international peptide sources — those are not legal for human use and have unverified purity.
4. Branded Ozempic via telehealth (~$399/mo)
If you specifically need branded Ozempic (some patients prefer to keep the same brand their physician started them on), branded Ozempic through telehealth typically runs around $399 per month, including the prescriber visit and shipment. This requires a clinically appropriate diagnosis on your chart.
Major telehealth options as of May 2026:
- Hims & Hers — fast onboarding, in-house pharmacy
- Ro — Body Program with coaching
- Lemonaid Health — pay per visit, not subscription
- LifeMD — wide GLP-1 menu
See our full telehealth provider comparison.
5. Run the comparison vs Wegovy and oral semaglutide
For most non-diabetic cash-pay patients, the right move is Wegovy NovoCare, not branded Ozempic. The new oral Wegovy 25 mg (FDA-approved early 2026) is also a no-needles option at a similar price point. Run the math:
- Wegovy vs Ozempic — same molecule, different cash-pay landscape
- How to Get Wegovy Without Insurance — full Wegovy playbook
- Ozempic vs Zepbound — semaglutide vs tirzepatide
- Cheapest GLP-1 finder — full ranking with $/lb breakdown
- Oral Wegovy 25 mg — daily pill version of semaglutide
Frequently asked questions
How much does Ozempic cost without insurance in 2026?
The list price (Wholesale Acquisition Cost) is $998 per 28-day supply, but almost no one pays that without coverage. The realistic cash-pay floor in May 2026 is roughly $199–$399 per month through telehealth platforms. Ozempic itself does not have a NovoCare self-pay program equivalent to the one for Wegovy.
Why is there no NovoCare self-pay program for Ozempic?
NovoCare's self-pay reference pricing is structured around Wegovy (the weight-loss-indicated brand), not Ozempic (the type 2 diabetes brand), even though they are the same molecule (semaglutide). For cash-pay patients without a diabetes diagnosis, Wegovy NovoCare at around $499/month is usually the cheapest legitimate path to semaglutide.
What is the Ozempic Savings Card?
The Ozempic Savings Card from Novo Nordisk reduces copay (often to ~$25/month) for patients whose commercial insurance already covers Ozempic for type 2 diabetes. Apply at ozempic.com. Government insurance — Medicare, Medicaid, Tricare, VA — is excluded from the card by federal anti-kickback rules. The card cannot be used by patients off-labeling Ozempic for weight loss without a diabetes diagnosis on the chart.
Should I switch from Ozempic to Wegovy to save money?
If you do not have type 2 diabetes, almost certainly yes. Wegovy is the same molecule (semaglutide) approved for chronic weight management, NovoCare self-pay starts around $499/month, and Wegovy reaches 14.9% peak weight loss versus Ozempic's 11.6% — the higher Wegovy max dose (2.4 mg vs Ozempic's 2.0 mg) drives the difference. If you DO have type 2 diabetes and your insurance covers Ozempic, the diabetes-channel copay is usually the cheapest path.
Will my insurance cover Ozempic for weight loss?
Almost never. Ozempic's FDA-approved indications are type 2 diabetes and cardiovascular risk reduction in T2D patients. If you do not have a diabetes diagnosis (or the related ICD-10 code on your chart), commercial and government insurers will deny coverage when prescribed for weight loss. The pathway to insurance-covered semaglutide for weight loss is Wegovy, not Ozempic — and even Wegovy coverage is plan-dependent and often requires prior authorization.
Is compounded semaglutide still available in 2026?
Limited. The FDA officially ended the semaglutide drug shortage in 2024–2025, removing the regulatory shield for most compounded versions. Some 503A pharmacies still produce personalized formulations on a case-by-case basis through licensed telehealth, but availability is much narrower than during the 2023–2024 boom. Verify the pharmacy is US-licensed and PCAB-accredited before ordering. Avoid international "research peptide" sources — those are not legal for human use.
How does Ozempic cost compare to Wegovy?
Ozempic has a lower list price ($998/month vs Wegovy's $1,349/month) but no manufacturer self-pay program. The cheapest paths are: Ozempic telehealth $399/month branded or $199/month compounded; Wegovy NovoCare $499/month self-pay or $449/month branded telehealth. For cash-pay weight-loss patients, Wegovy usually wins on cost-per-pound-lost.
Can I use a GoodRx coupon for Ozempic?
Coupons rarely beat telehealth pricing for Ozempic. Like Wegovy and Zepbound, Ozempic is brand-name and patent-protected, so retail pharmacy cash prices stay close to the WAC even with coupons. GoodRx Care's telehealth subscription ($39/month) plus pharmacy cost is occasionally competitive but for most cash-pay patients, branded telehealth or — for non-diabetic users — switching to Wegovy NovoCare is the cheaper path.
Stay ahead of every GLP-1 development
We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.